CVE-2020-37094
Espocrm vulnerability
- Published3 Feb 2026
Description
EspoCRM 5.7.0 prior to 5.9.0 contains an authentication token reuse vulnerability that allows authenticated attackers to bypass two-factor authentication by exploiting token-to-password-hash mapping in application/Espo/Core/Utils/Authentication/Espo.php. Attackers can obtain an authentication token for a controlled account and replay it against any victim account sharing the same password, since tokens are bound to password hashes rather than unique per-user values, bypassing the victim's 2FA protections.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:NAffected products
Remediation
No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2020-37094 being actively exploited?
CVE-2020-37094 is not in the CISA KEV catalog. A public exploit reference exists, so treat it as exploitable. Its EPSS exploit probability is 0.53%.
How severe is CVE-2020-37094?
CVE-2020-37094 has a CVSS 3.1 base score of 8.1, rated high. EPSS estimates a 0.53% probability of exploitation.
Which products are affected by CVE-2020-37094?
Affected products include Espocrm.
How do I fix CVE-2020-37094?
Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2020-37094 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.